NASDAQ: SBRASabra Health Care Reit Inc Stock
$19.54+0.23 (+1.19%)
Updated Jun 26, 2026
SBRA Price
$19.54
Fair Value Price
N/A
Market Cap
$4.93B
52 Week Low
$17.17
52 Week High
$21.27
P/E
31.02x
P/B
1.77x
P/S
5.97x
PEG
3.09x
Dividend Yield
6.14%
Revenue
$812.84M
Earnings
$156.19M
Gross Margin
100%
Operating Margin
33.45%
Profit Margin
19.2%
Debt to Equity
1.01
Operating Cash Flow
$367M
Beta
0.47
Next Earnings
Aug 3, 2026
Ex-Dividend
N/A
Next Dividend
N/A
SBRA Overview
As of March 31, 2022, Sabra Health Care REIT, Inc. held a diverse investment portfolio. This largely comprised 416 income-generating real estate properties, which included: 279 skilled nursing and transitional care facilities; 59 senior living communities operating under lease agreements; 50 senior housing properties managed by external operators; 13 behavioral health centers; and 15 specialized hospitals and other healthcare sites. In addition to its real estate holdings, Sabra's portfolio also featured: a single asset earmarked for sale; one sales-type lease arrangement; a total of 16 loan receivables, consisting of two mortgage loans, one construction loan, and thirteen other debt instruments; seven preferred equity stakes; and an interest in one unconsolidated joint venture. Collectively, these 416 investment properties offered a capacity of 41,445 beds and residential units, geographically distributed across both the United States and Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SBRA's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Healthcare Facility REIT
Industry Rating
D
SBRA
Ranked#15 of 17
Ranked#15 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $13.60 | B | |
| $14.91 | C | |
| $18.33 | C |
Be the first to know about important SBRA news, forecast changes, insider trades & much more!
SBRA News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SBRA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SBRA ($19.54) is trading above its intrinsic value of $5.51, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SBRA is poor value based on its earnings relative to its share price (31.02x), compared to the US market average (12.39x)
P/E vs Market Valuation
SBRA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more SBRA due diligence checks available for Premium users.
Valuation
SBRA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
31.02x
Industry
96.76x
Market
12.39x
SBRA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SBRA is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
SBRA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.77x
Industry
2.89x
SBRA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SBRA price to earnings growth (PEG)
For valuing profitable companies with growth potential
SBRA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
SBRA's financial health
Profit margin
Revenue
$221.8M
Net Income
$40.9M
Profit Margin
18.4%
SBRA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.6B
Liabilities
$2.8B
Debt to equity
1.01
SBRA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SBRA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$98.4M
Investing
-$105.1M
Financing
$52.1M
SBRA vs Healthcare Facility REIT Stocks
Sabra Health Care Reit Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.